#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue necrosis Autoimmune haemolytic anaemia Gestational trophoblastic tumour Kidney transplant rejection Guillain-Barre syndrome Pelizaeus-Merzbacher disease Rhabdomyosarcoma recurrent Ewing's sarcoma metastatic PIK3CA-activated mutation Non-small cell lung cancer Follicular lymphoma X-linked lymphoproliferative syndrome Lymphangioma Malformation venous Synovial sarcoma recurrent More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Treatment MELAS syndrome – Basic Information Medulloblastoma – Trials in Disease Primary mediastinal large B-cell lymphoma Hairy cell leukaemia – Treatment Cytokine release syndrome – Treatment Choroid melanoma Testicular leiomyosarcoma Amyotrophic lateral sclerosis – Basic Information Gaucher’s disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pemetrexed Diacid Monohydrate Enlicitide Chloride Azd3427 10-1074-Ls Dazodalibep AZD4512 LVT-001 Pasireotide Melatonin BLEXIMENIB Xp-Dc+Tl+Klh Bepranemab Triptorelin Acetate Elotuzumab RPTR-1-201 Rosuvastatin Calcium Ixekizumab GRAPHITE Norfloxacin Efepoetin Alfa More therapies…

    Learn about Your Condition

    Mesothelioma Primary biliary cholangitis Abdominal wall pain Ocular myasthenia Bone sarcoma Naevus flammeus Oesophageal disorder Chondroplasty EGFR gene mutation Behcet's syndrome Retinopathy proliferative Oral neoplasm Amyotrophic lateral sclerosis Pleomorphic liposarcoma Sarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

    Not recruiting

    2 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    • Hereditary angioedema
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    Austria Bulgaria Germany Ireland Italy Poland

  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Obinutuzumab
    Czechia France Italy Poland Spain

  • Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Graft versus host disease
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    Germany Italy Spain

  • Study on Methotrexate and Metformin for Patients with Rheumatoid Arthritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Methotrexate
    • Metformin Hydrochloride
    France

  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Germany Hungary Italy Poland Slovakia

  • Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France
Previous Page
1 … 10 11 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!